Entellus Medical
acquired by StrykerPlymouth, US · Delaware corporation · 1 known investors
Find your way into Entellus Medical
Acquired by Stryker Corporation December 2017 · $662M ($24.00 per share, equity value ~$662 million) · source ↗
Entellus Medical designed and marketed minimally invasive ENT devices, including the XprESS Multi-Sinus Dilation System and LATERA nasal implant, for office-based sinus treatments.
Founders & leadership
JK
John K. BakewellNamed on SEC filing
BE
Brian E. FarleyNamed on SEC filing
ST
Shawn T McCormickNamed on SEC filing
DB
David B. MilneNamed on SEC filing
DR
Douglas RohlenNamed on SEC filing
SR
Stephen R. PaidoshNamed on SEC filing
RS
Robert S. WhiteNamed on SEC filing
KL
Kevin L. MensinkNamed on SEC filing
MJ
Martha J. ChristianNamed on SEC filing
MH
Michael H. RosenthalNamed on SEC filing
TB
Timothy B. PetrickNamed on SEC filing
Board
JC
James C. MomtazeeBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$50M disclosed across 1 round · 2017
▶$50MraisedJul 2017 · 45 investors · Other Health CareRule 506(b)
▶$50MraisedJul 2017 · 45 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John K. BakewellDirector
- Brian E. FarleyDirector
- Shawn T McCormickDirector
- David B. MilneDirector
- Douglas RohlenDirector
- Stephen R. PaidoshExecutive Officer
- Robert S. WhiteExecutive Officer, Director
- Kevin L. MensinkExecutive Officer
- Martha J. ChristianExecutive Officer
- Michael H. RosenthalExecutive Officer
- James C. MomtazeeDirector
- Timothy B. PetrickExecutive Officer
- Thomas P. WilliamsonExecutive Officer
- Jonelle R. BurnhamExecutive Officer
- Donald A. GonzalesExecutive Officer
- Guido NeelsDirector
- Brent A. MoenExecutive Officer
- Joshua J. BaltzellDirector
- Karen E. PetersonExecutive Officer
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Entellus Medical do?
- Entellus Medical designed and marketed minimally invasive ENT devices, including the XprESS Multi-Sinus Dilation System and LATERA nasal implant, for office-based sinus treatments.
- Who are Entellus Medical's investors?
- Entellus Medical's investors include Sofinnova Ventures.
- How much funding has Entellus Medical raised?
- Entellus Medical has disclosed $50M raised across 1 round.
- Who acquired Entellus Medical?
- Entellus Medical was acquired by Stryker.
- Where is Entellus Medical headquartered?
- Entellus Medical is headquartered in Plymouth, US.